Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Adeojo LW"'
Autor:
Adeojo LW; Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California San Francisco, San Francisco, CA 94143-0912, USA., Patel RC; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA., Sambol NC; Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California San Francisco, San Francisco, CA 94143-0912, USA.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2024 Aug 07; Vol. 16 (8). Date of Electronic Publication: 2024 Aug 07.
Autor:
Nasser A; Supernus Pharmaceuticals, Inc., Rockville, Maryland., Randall Owen J; Navitor Pharmaceuticals, Inc., Boston, Massachusetts., Gomeni R; Pharmacometrica, Lieu-dit Longcol, La Fouillade, France., Kosheleff AR; Supernus Pharmaceuticals, Inc., Rockville, Maryland., Portelli J; Supernus Pharmaceuticals, Inc., Rockville, Maryland., Adeojo LW; Supernus Pharmaceuticals, Inc., Rockville, Maryland., Hughes TE; Navitor Pharmaceuticals, Inc., Boston, Massachusetts. Electronic address: thughes@navitorpharma.com.
Publikováno v:
Clinical therapeutics [Clin Ther] 2024 Mar; Vol. 46 (3), pp. 217-227. Date of Electronic Publication: 2024 Mar 13.
Autor:
Wang Z; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Kosheleff AR; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Adeojo LW; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Odebo O; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Liranso T; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Schwabe S; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Nasser A; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA. anasser@supernus.com.
Publikováno v:
European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2022 Jan; Vol. 47 (1), pp. 69-79. Date of Electronic Publication: 2021 Oct 15.
Autor:
Nasser A; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Gomeni R; Pharmacometrica, Lieu-dit Longcol, La Fouillade, France., Wang Z; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Kosheleff AR; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Xie L; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Adeojo LW; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Schwabe S; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2021 Dec; Vol. 61 (12), pp. 1626-1637. Date of Electronic Publication: 2021 Aug 08.
Autor:
Wang Z; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Kosheleff AR; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Adeojo LW; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Odebo O; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Adewole T; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Qin P; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Maletic V; Department of Psychiatry/Behavioral Science, University of South Carolina School of Medicine, Greenville, South Carolina, USA., Schwabe S; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Nasser A; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 Nov; Vol. 10 (11), pp. 1365-1374. Date of Electronic Publication: 2021 May 04.
Autor:
Cushion MT; Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio, USA., Kumar P; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Lu R; Matinas BioPharma Inc, Bedminster, New Jersey, USA., Ashbaugh A; Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Adeojo LW; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Alfaro R; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Mannino R; Matinas BioPharma Inc, Bedminster, New Jersey, USA., Tramont E; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Kovacs JA; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2021 Jul 15; Vol. 224 (2), pp. 326-331.
Autor:
Kim H; Juvenile Myositis Pathogenesis and Therapeutics Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA hanna.kim@nih.gov.; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Dill S; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., O'Brien M; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Vian L; Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Li X; Biostatistics and Clinical Epidemiology Service, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Manukyan M; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Jain M; Rehabilitation Medicine Department, Physical Therapy Section, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Adeojo LW; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., George J; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Perez M; Pediatric Rheumatology, Cook Children's Medical Center, Fort Worth, Texas, USA., Grom AA; Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Sutter M; Department of Rheumatology, Children's Hospital Colorado, Aurora, Colorado, USA.; Pediatrics Rheumatology, University of Colorado Denver, Denver, Colorado, USA., Feldman BM; Division of Rheumatology, Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada., Yao L; Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Millwood M; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Brundidge A; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Pichard DC; Dermatology Branch, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Cowen EW; Dermatology Branch, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Shi Y; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Lu S; Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Tsai WL; Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Gadina M; Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Rider LG; Environmental Autoimmunity Group, NIEHS/NIH/DHHS, Bethesda, Maryland, USA., Colbert RA; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Mar; Vol. 80 (3), pp. 406-408. Date of Electronic Publication: 2020 Aug 25.
Autor:
Park LT; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., Kadriu B; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., Gould TD; Veterans Affairs Maryland Health Care System, Baltimore, MD.; Departments of Psychiatry, Pharmacology, Anatomy & Neurobiology and Physiology, University of Maryland School of Medicine, Baltimore, MD., Zanos P; Departments of Psychiatry, Pharmacology, Anatomy & Neurobiology and Physiology, University of Maryland School of Medicine, Baltimore, MD., Greenstein D; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., Evans JW; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., Yuan P; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., Farmer CA; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., Oppenheimer M; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., George JM; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health, Bethesda, MD., Adeojo LW; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health, Bethesda, MD., Snodgrass HR; VistaGen Therapeutics, Inc., San Francisco, CA., Smith MA; VistaGen Therapeutics, Inc., San Francisco, CA.; Medical College of Georgia, Augusta, GA., Henter ID; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD., Machado-Vieira R; Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Science Center, Houston, TX., Mannes AJ; Clinical Center, Department of Perioperative Medicine, National Institutes of Health, Bethesda, MD., Zarate CA; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
Publikováno v:
The international journal of neuropsychopharmacology [Int J Neuropsychopharmacol] 2020 Jul 29; Vol. 23 (7), pp. 417-425.